Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05147597 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Turkish Validity and Reliability of SGRQ-I

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Primary completion date changed from estimate of Jan 1, 2026 to May 1, 2025
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Study description expanded, about 5 words
  2. Primary and study completion dates: Jan 1, 2025 to Jan 1, 2026v5
  3. Primary and study completion dates: Jan 1, 2024 to Jan 1, 2025v4
  4. Primary and study completion dates: Jan 1, 2023 to Jan 1, 2024v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2022 to Jan 9, 2022
    • Site details revised
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Saint George Respiratory Questionnaire (SGRQ) questionnaire is a frequently used questionnaire in the respiratory patient group, and the Turkish version of this questionnaire, which was created for use in idiopathic pulmonary fibrosis patients, is not available. There is no commonly used quality of life questionnaire in patients with idiopathic pulmonary fibrosis. The aim of the study is to translate and validate the SGRQ idiopathic pulmonary fibrosis version of questionnaire into Turkish.
Trial Details
NCT Number NCT05147597
Lead Sponsor Saglik Bilimleri Universitesi
Conditions
(from sponsor)		 IPF
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov